DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Swain SM, Baselga J, Miles D. et al.
Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA.
Ann Oncol 2014;
25: 1116-1121 . doi:10.1093/annonc/mdu133
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.